Skin of Color
Neal Bhatia, MD, FAAD
Biologics and new JAK inhibitors play an important role in managing psoriasis. Neal Bhatia, MD offers his thoughts on when and why these treatments should be considered.
Jerry Bagel, MD, FAAD
A. Yasmine Kirkorian, MD
Study: Long-Term Use of Brodalumab Is Safe, Effective
Increased Adherence, Symptom Improvement Seen When Psoriasis Patients Switch to IL-17 Blockers